Arbutus Biopharma Corp (ABUS)
3.46
+0.02
(+0.58%)
USD |
NASDAQ |
Nov 21, 16:00
3.46
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Price to Book Value: 6.134 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 6.098 |
| November 19, 2024 | 6.187 |
| November 18, 2024 | 6.240 |
| November 15, 2024 | 6.453 |
| November 14, 2024 | 6.435 |
| November 13, 2024 | 6.471 |
| November 12, 2024 | 6.453 |
| November 11, 2024 | 6.612 |
| November 08, 2024 | 6.648 |
| November 07, 2024 | 6.612 |
| November 06, 2024 | 6.949 |
| November 05, 2024 | 7.020 |
| November 04, 2024 | 6.861 |
| November 01, 2024 | 7.018 |
| October 31, 2024 | 6.814 |
| October 30, 2024 | 6.983 |
| October 29, 2024 | 7.16 |
| October 28, 2024 | 7.178 |
| October 25, 2024 | 7.036 |
| October 24, 2024 | 7.178 |
| October 23, 2024 | 7.195 |
| October 22, 2024 | 7.142 |
| October 21, 2024 | 7.213 |
| October 18, 2024 | 7.355 |
| October 17, 2024 | 7.302 |
| Date | Value |
|---|---|
| October 16, 2024 | 7.444 |
| October 15, 2024 | 7.284 |
| October 14, 2024 | 6.841 |
| October 11, 2024 | 6.876 |
| October 10, 2024 | 6.717 |
| October 09, 2024 | 6.664 |
| October 08, 2024 | 6.682 |
| October 07, 2024 | 6.611 |
| October 04, 2024 | 6.806 |
| October 03, 2024 | 6.823 |
| October 02, 2024 | 6.912 |
| October 01, 2024 | 6.788 |
| September 30, 2024 | 6.823 |
| September 27, 2024 | 5.904 |
| September 26, 2024 | 6.105 |
| September 25, 2024 | 6.028 |
| September 24, 2024 | 6.198 |
| September 23, 2024 | 6.228 |
| September 20, 2024 | 6.198 |
| September 19, 2024 | 6.382 |
| September 18, 2024 | 6.367 |
| September 17, 2024 | 6.29 |
| September 16, 2024 | 6.568 |
| September 13, 2024 | 6.891 |
| September 12, 2024 | 6.644 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.776
Minimum
May 10 2022
7.444
Maximum
Oct 16 2024
3.505
Average
2.886
Median
May 18 2023
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.233 |
| Amicus Therapeutics Inc | 15.85 |
| Ionis Pharmaceuticals Inc | 8.091 |
| GlycoMimetics Inc | 1.821 |
| FibroGen Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 92.54 |
| Price | 3.46 |
| Earnings Yield | -12.43% |
| Market Cap | 655.64M |